Trends in the utilization and wastage of coagulation factor concentrates: The application of a regional tracking programme

Haemophilia

Volumn 13, Issue 3, 2007, Pages 271-278

  Arnold, Donald M ^a,b   Webert, K E ^a,b   Carruthers, J ^a   Almonte, T ^c   Decker, K ^c   Seroski, W ^c   Reed, J ^b   Chan, A K C ^a   Pai, M ^a   Walker, I ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Blood transfusion; Coagulation factors; Haemophilia; Health resource utilization

Indexed keywords

BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CANADA; CHILD; COMPUTER PROGRAM; COST CONTROL; DRUG MONITORING; DRUG UTILIZATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEMOPHILIA A; HEMOPHILIA B; HOME CARE; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; HEALTH CARE COSTS; HEMOPHILIA A; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; MULTICENTER STUDIES; ONTARIO; PATIENT CARE;

EID: 34248591028     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01452.x     Document Type: Article

References (15)

1. Arnold DM, Julian JA, Walker IR. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over twenty-one years of follow up. Blood 2006; 108: 460-4.
2. Canadian Hemophilia Clinic Directors Group. Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. BMJ 1993; 306: 306-7.
3. Blanchette V, Walker I, Gill P, Adams M, Roberts R, Inwood M. Hepatitis C infection in patients with hemophilia: Results of a national survey. Canadian Hemophilia Clinic Directors Group. Transfus Med Rev 1994; 8: 210-7.
4. Health Canada. Krever Commission Report. Public Works and Government Services, Ottawa, Canada, 1997. Available at: http://www.hc-sc.gc.ca/ ahc-asc/activit/com/krever_e.html (accessed on 7 January 2007).
5. Blajchman MA, Goldman M, Webert KE, Vamvakas EC, Hannon J, Delage G. Proceedings of a consensus conference: The screening of blood donors for variant CJD. Transfus Med Rev 2004; 18: 73-92.
6. Llewelyn CA, Hewitt PE, Knight RS et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-21.
7. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-9.
8. Walker IR, Sek JT, Almonte TM et al. Developing a tracking system for coagulation factor concentrates in southern Ontario. Transfusion 2003; 43: 556-62.
9. Walker I, Sigouin C, Sek J et al. Comparing hand-held computers and paper diaries for haemophilia home therapy: A randomized trial. Haemophilia 2004; 10: 698-704.
10. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. 2005. Available at: http://www.wfh.org (accessed on 5 April 2006).
11. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004; 104: 3858-64.
12. Boffard KD, Riou B, Warren B et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 8-15.
13. Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-85.
14. Friederich PW, Henny CP, Messelink EJ et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial. Lancet 2003; 361: 201-5.
15. Stonebraker JS, Amand RE, Nagle AJ. A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community. Haemophilia 2003; 9: 245-50.